Neuronal molecule that make prostate cancer more aggressive identified in recent study Isra Zaman25 Jan 2023 9:45 AM ISTProstate cancer is the second most common cancer and the second leading cause of cancer death among American men. Now, researchers have discovered key...
Novartis gets European Commission nod for Pluvicto to treat progressive PSMA-positive metastatic castration-resistant prostate cancer Ruchika Sharma17 Jan 2023 3:30 PM ISTPluvicto is an intravenous radioligand therapy combining a targeting compound (a ligand) with a therapeutic radionuclide (a radioactive particle, in...
MRI-guided radiotherapy found beneficial for patients with localized prostate cancer Isra Zaman14 Jan 2023 9:30 AM ISTResults from the first randomized phase III clinical trial to directly compare MRI-guided stereotactic body radiotherapy (SBRT) with the same therapy...
Prostate cancer recurrence can be accurately detected by PSMA PET/MRI Dr. Kamal Kant Kohli8 Jan 2023 8:00 PM ISTUSA: PSMA (prostate-specific membrane antigen) PET/MRI can successfully determine whether the cancer is likely to return within two years of...
Zydus Gets CDSCO panel Nod for BE Study Of Antineoplastic Drug Relugolix Dr. Divya Colin2 Jan 2023 5:30 PM ISTNew Delhi: In response to the drug major Zydus proposal for manufacture and market of anticancer drug Relugolix Tablets 120mg along with...
Whole-body SPECT/CT with CZT system significantly cuts scan time for metastases detection in prostate cancer Medha Baranwal20 Dec 2022 8:00 PM ISTFinland: A recent study has found that faster acquisition techniques could cut whole-body SPECT/CT bone scan times by half to detect metastatic tumors...
Medical Bulletin 15/December/2022 Isra Zaman15 Dec 2022 1:45 PM ISTHere are the top medical news for the day:Type 2 diabetes may be reversed by Intermittent fasting Intermittent fasting diets have become popular in...
Exercise, even in late stages of the disease suppresses growth of cancer cells Isra Zaman15 Dec 2022 9:30 AM ISTPrevious work from ECU's Exercise Medicine Research Institute has shown men with advanced prostate cancer can change the chemical environment of...
Novartis prostate cancer therapy Pluvicto bags European Commission nod Ruchika Sharma14 Dec 2022 4:15 PM IST"The approval of Pluvicto by the European Commission marks a major milestone for patients with advanced prostate cancer who have few alternative...
Single-fraction stereotactic body radiotherapy promising for local prostate cancer recurrence Dr.Niharika Harsha B6 Dec 2022 7:30 PM ISTResearchers from Germany found that even in intensively pretreated prostate cancer patients single-fraction, PSMA-PET- and mpMRI-guided focal...
Cipla unveils Leuprolide Acetate Injection Depot for advanced prostate cancer in US Ruchika Sharma29 Nov 2022 1:00 PM ISTMumbai: Pharma major Cipla Limited and its wholly owned subsidiary Cipla USA Inc., today announced the launch of Leuprolide Acetate Injection Depot ...
High dose Estetrol curbs hot flushes and improves QOl in prostate cancer patients on ADT Dr.Niharika Harsha B22 Nov 2022 8:00 PM ISTA new study found that high-dose fetal estrogen estetrol along with androgen deprivation therapy prevented the occurrence of hot flushes and improved...
